Company profile
InvenireX - Ultrasensitive DNA Detection
InvenireX is developing real-time, ultra-sensitive Nucleic Acid detection instrumentation powered by the latest object-detection neural networks, to empower our Scientists to accelerate life-sciences research.
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
CH01 | Transaction MzQzNTMwMTk0MWFkaXF6a2N4
Published 11 Sep 2024 15:22
TM01 | Transaction MzQzNTI2OTI5NWFkaXF6a2N4
Published 11 Sep 2024 10:36
AA | Transaction MzQzMTg1MTc0NmFkaXF6a2N4
Published 12 Aug 2024 12:51
Company registered at Companies House
1 Sep 2025 to 31 Aug 2026
A new generation of medicines---such as RNA-based therapies and vaccines---relies on delivering genetic instructions directly into cells. This is typically achieved using lipid nanoparticles (LNPs): microscopic, fat-based spheres that encapsulate RNA and carry it safely to target cells. While LNPs have proven vital in recent advances, particularly during ...
